Efficacy of Intrauterine Lidocaine and Naproxen for Pain Control With Intrauterine Device Insertion

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the efficacy of intrauterine lidocaine and oral naproxen sodium on discomfort and pain of patients undergoing intrauterine device insertion.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Walter Reed National Military Medical Center
• Treatments: Lidocaine; Naproxen

Criteria

Inclusion Criteria:

• DEERS-eligible reproductive age women (i.e. Tricare beneficiaries)

• age 18 years and older

• desiring Paragard or Mirena intrauterine device insertion

Exclusion Criteria:

• Current pregnancy

• cervical stenosis

• severe medical illness

• known allergy or sensitivity to lidocaine or naproxen

• peptic ulcer disease

• current pelvic inflammatory disease

• patients with known renal insufficiency

• patients using chronic NSAIDs or on chronic pain medication

• women desiring Skyla IUD insertion will also be excluded due to infrequency of insertions at WRNMMC